ASAN FOUNDATION
๐ฐ๐ทSouth Korea
- Country
- ๐ฐ๐ทSouth Korea
- Ownership
- Private
- Established
- 1989-06-23
- Employees
- 501
- Market Cap
- -
- Website
- https://ails.amc.seoul.kr
Gemcitabine-Carboplatin Versus Gemcitabine-Oxaliplatin in Cisplatin-unfit Urothelial Carcinoma
- First Posted Date
- 2011-12-08
- Last Posted Date
- 2014-09-25
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 80
- Registration Number
- NCT01487915
- Locations
- ๐ฐ๐ท
Korea University Anam Hospital, Seoul, Korea, Republic of
๐ฐ๐ทKeimyeong University Dongsan Medical Center, Daegu, Korea, Republic of
๐ฐ๐ทChungnam University Hospital, Daejeon, Korea, Republic of
The Role of Androgen Deprivation Treatment (ADT) in Docetaxe-Prednisolone Chemotherapy for Castrate-Resistant Prostatic Cancer
- First Posted Date
- 2011-12-08
- Last Posted Date
- 2011-12-08
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 90
- Registration Number
- NCT01487902
- Locations
- ๐ฐ๐ท
Asan Medical Center, Seoul, Korea, Republic of
GEMOX in Docetaxel-Refractory Castration-Resistant Prostate Cancer
- First Posted Date
- 2011-12-07
- Last Posted Date
- 2013-12-03
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 33
- Registration Number
- NCT01487720
- Locations
- ๐ฐ๐ท
Asan Medical Center, Seoul, Korea, Republic of
RAD001 in Advanced Gastric Cancer Who Failed Standard First-line Treatment With pS6 Ser 240/4 Expression
- First Posted Date
- 2011-11-30
- Last Posted Date
- 2020-01-07
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 45
- Registration Number
- NCT01482299
- Locations
- ๐ฐ๐ท
Asan Medical Center, Songpa-gu, Seoul, Korea, Republic of
Prevalence of Metabolic Syndrome in Patients With Schizophrenia in Korea
- Conditions
- First Posted Date
- 2011-11-23
- Last Posted Date
- 2011-11-23
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 1000
- Registration Number
- NCT01477918
- Locations
- ๐ฐ๐ท
Asan medical center, Seoul, Korea, Republic of
Efficacy of Docetaxel, Capecitabine, Cisplatin, and Bevacizumab in Patients With Unresectable Advanced Gastric Cancer
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2011-11-15
- Last Posted Date
- 2020-01-07
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 31
- Registration Number
- NCT01471470
- Locations
- ๐ฐ๐ท
Asan Medical Center, Seoul, Korea, Republic of
Efficacy Study of Neoadjuvant Chemotherapy to Treat Advanced Ovarian Cancer
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2011-10-31
- Last Posted Date
- 2017-05-31
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 43
- Registration Number
- NCT01462149
- Locations
- ๐ฐ๐ท
Asan Medical Center, Seoul, Korea, Republic of
Efficacy and Safety Study of Concurrent Chemoradiation Therapy to Treat Locally Advanced Cervical Cancer
Phase 3
Terminated
- Conditions
- Interventions
- First Posted Date
- 2011-10-28
- Last Posted Date
- 2017-05-31
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 21
- Registration Number
- NCT01461772
- Locations
- ๐ฐ๐ท
Asan Medical Center, Seoul, Korea, Republic of
Efficacy Study of Chemotherapy to Treat Advanced or Recurrent Endometrial Cancer
- First Posted Date
- 2011-10-28
- Last Posted Date
- 2017-05-31
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 59
- Registration Number
- NCT01461759
- Locations
- ๐ฐ๐ท
Asan Medical Center, Seoul, Korea, Republic of
Efficacy Study of Chemotherapy Followed by Radiation Therapy to Treat Endometrial Cancer
Phase 2
- Conditions
- Interventions
- First Posted Date
- 2011-10-28
- Last Posted Date
- 2017-05-31
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 67
- Registration Number
- NCT01461746
- Locations
- ๐ฐ๐ท
Asan Medical Center, Seoul, Korea, Republic of
ยฉ Copyright 2024. All Rights Reserved by MedPath